[Case of malignant histiocytosis treated with chop therapy and splenectomy]. 1994

Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama

UI MeSH Term Description Entries
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013156 Splenectomy Surgical procedure involving either partial or entire removal of the spleen. Splenectomies
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine
D054747 Histiocytic Sarcoma Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid. Histiocytosis, Malignant,Malignant Histiocytosis,True Histiocytic Lymphoma,True Malignant Histiocytosis,Histiocytic Lymphoma, True,Histiocytic Lymphomas, True,Histiocytic Sarcomas,Histiocytoses, Malignant,Histiocytoses, True Malignant,Histiocytosis, True Malignant,Lymphoma, True Histiocytic,Lymphomas, True Histiocytic,Malignant Histiocytoses,Malignant Histiocytoses, True,Malignant Histiocytosis, True,Sarcoma, Histiocytic,Sarcomas, Histiocytic,True Histiocytic Lymphomas,True Malignant Histiocytoses

Related Publications

Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
December 1990, Japanese journal of clinical oncology,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
May 1982, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
March 2009, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
March 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
December 1986, Nihon Kyobu Shikkan Gakkai zasshi,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
January 1981, Haematology and blood transfusion,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
April 1991, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
July 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
August 1987, Gan no rinsho. Japan journal of cancer clinics,
Y Kitano, and M Nakagawa, and M Kojima, and H Kumagai, and G Tani, and M Komatsu, and M Nara, and S Nakano, and K Oyashiki, and K Toyama
January 1986, Pediatric pathology,
Copied contents to your clipboard!